Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
07/2012
07/26/2012WO2012068355A3 Treating aortic aneurysm by modulating toll-like receptors
07/26/2012WO2012033353A3 Sesterterpene compounds and use thereof
07/26/2012US20120190740 Use of dronedarone for the preparation of a drug for use in the management of the risk of liver injury
07/26/2012US20120190731 Methods and compositions to reduce oxidative stress
07/26/2012US20120190721 Method for treating nervous system disorders and conditions
07/26/2012US20120190716 Methods and uses of cytochrome p450 inhibitors
07/26/2012US20120190701 Renin inhibitors
07/26/2012US20120190699 Pyridones useful as inhibitors of kinases
07/26/2012US20120190696 Inhibitors of fatty acid binding protein (fabp)
07/26/2012US20120190689 Piperazinyl 3-aminopyrrolidine derivatives as a ccr2 antagonist
07/26/2012US20120190680 Heteroaryl Amide Analogues
07/26/2012US20120190678 Substituted pyrazolo-quinazoline derivatives as kinase inhibitors
07/26/2012US20120190674 Sulfonamides as trpm8 modulators
07/26/2012US20120190655 Intravenous Formulation with Water-Soluble CoCrystals of Acetylsalicylic Acid and Theanine
07/26/2012US20120190654 Novel bicyclic urea compounds
07/26/2012US20120190651 Anti-inflammatory compounds
07/26/2012US20120190649 Bicyclic aryl sphingosine 1-phosphate analogs
07/26/2012US20120190639 Treatment or prophylaxis of proliferative conditions
07/26/2012US20120190634 Lipoteichoic acid-derived glycolipids, and compositions comprising same
07/26/2012US20120190624 Psi-epsilon rack peptide composition and method for protection against tissue damage due to ischemia
07/26/2012US20120190616 Analogues of Insulin-Like Growth Factor-1 (IGF-1) Having Amino Acid Substitution at Position 59
07/26/2012US20120190612 Methods of treatment
07/26/2012US20120190610 Tetranectin-apolipoprotein a-i, lipid particles containing it and its use
07/26/2012US20120190003 Organ arrest, protection, preservation and recovery
07/26/2012US20120189723 Herbal composition for reducing add/adhd and method thereof
07/26/2012US20120189694 Co-precipitate comprising a phosphodiesterase-5 inhibitor (pde-5-inhibitor) and a pharmaceutically compatible carrier, production and use thereof
07/26/2012US20120189693 Oral dosage forms
07/26/2012US20120189688 Carrier component and fabrication method thereof
07/26/2012US20120189687 Compositions and Methods for Topical Application of Growth Factors and Cytokines
07/26/2012US20120189679 Method for coating powders
07/26/2012US20120189667 Method for repairing or replacing damaged tissue
07/26/2012US20120189642 Iminothiadiazine dioxide compounds as bace inhibitors, compositions, and their use
07/26/2012US20120189631 Pharmaceutical composition for treating ischemic events
07/26/2012US20120189626 Treatment of complement-associated disorders
07/26/2012US20120189624 Treatment and prophylaxis of amyloidosis
07/26/2012US20120189621 Combination Therapies and Methods Using Anti-CD3 Modulating Agents and Anti-IL-6 Antagonists
07/26/2012US20120189616 Isosorbide nitrates
07/26/2012US20120189615 CROSS-ß STRUCTURE COMPRISING AMYLOID-BINDING PROTEINS AND METHODS FOR DETECTION OF THE CROSS-ß STRUCTURE, FOR MODULATING CROSS-ß STRUCTURES FIBER FORMATION AND FOR MODULATING CROSS-ß STRUCTURE-MEDIATED TOXICITY
07/26/2012US20120189612 Compositions and methods for treating cancer while preventing or reducing cardiotoxicity and/or cardiomyopathy
07/26/2012US20120189604 Purification and isolation of recombinant oxalate degrading enzymes and spray-dried particles containing oxalate degrading enzymes
07/26/2012US20120189602 Treatment and prevention of pulmonary conditions
07/26/2012US20120189541 Dual Variable Domain Immunnoglobulins and Uses Thereof
07/26/2012US20120189538 Use of a2a adenosine receptor agonists
07/26/2012CA2824460A1 Azetidine derivatives useful for the treatment of metabolic and inflammatory diseases
07/26/2012CA2824437A1 Diazeniumdiolate derivatives
07/26/2012CA2824344A1 Mineralocorticoid receptor antagonists
07/26/2012CA2824316A1 Organic amine salts of azilsartan, preparation method and use thereof
07/25/2012EP2479175A1 Compounds and methods for treating dyslipidemia
07/25/2012EP2478002A2 Small peptide modulators of potassium channel trafficking
07/25/2012EP2477989A1 COMPOUNDS HAVING TAFIa INHIBITORY ACTIVITY
07/25/2012EP2477988A1 Acetylene derivatives of 5-phenyl-pyrazolopyridine, preparation thereof, and therapeutic use thereof
07/25/2012EP2477977A2 Treatment for oxidative stress and/or hypertension
07/25/2012EP2477641A2 Inhibition of endosomal toll-like receptor activation
07/25/2012EP2477640A2 Methods of treating a patient receiving a cardiac stent implant
07/25/2012EP2477594A1 Isoketal scavengers and mitigation of disorders involving oxidative injury
07/25/2012EP2477494A1 Na/k-atpase ligands, ouabain antagonists, assays and uses thereof
07/25/2012EP2444492A9 Chicken-derived anti-lox-1 antibody
07/25/2012EP2292611B1 Novel thiophenediamine derivative having urea structure
07/25/2012EP2079688B1 Glucagon receptor antagonist compounds, compositions containing such compounds and their pharmaceutical use
07/25/2012EP1390349B1 Aminoquinoline and aminopyridine derivatives and their use as adenosine a3 ligands
07/25/2012EP1322641B1 Pharmaceutically active hydrophilic sulfonamide derivatives as inhibitors of protein junkinases
07/25/2012EP1109453B1 Compositions and methods for treatment of mitochondrial diseases
07/25/2012CN102612558A Pcsk9疫苗 Pcsk9 vaccine
07/25/2012CN102612524A Dual variable domain immunoglobulins and uses thereof
07/25/2012CN102605030A Enzymatic extraction method for oat peptide
07/25/2012CN102604951A Compositions and methods to treat muscular & cardiovascular disorders
07/25/2012CN102604803A Preparation method for ginseng-polygonum multiflorum nourishing solution
07/25/2012CN102604792A Method for producing health-care wine by utilizing pomelos and kudzuvine root
07/25/2012CN102604771A Medical wine production method
07/25/2012CN102603924A Method for separating sulodexide raw materials from heparin by-products
07/25/2012CN102603861A Tanshinone derivatives, medicine compositions thereof, and purposes thereof in medicine
07/25/2012CN102603751A Triazol (4,5-D) pyrimidine derivate and preparation method of triazol (4,5-D) pyrimidine derivate as well as application of triazol (4,5-D) pyrimidine derivate in drug preparation
07/25/2012CN102603734A Protein kinase inhibitor and application thereof
07/25/2012CN102603723A Azilsartan organic amine salts, and preparation method and application thereof
07/25/2012CN102603713A Chiral CB1 (cannabinoid) receptor inhibitor, and preparation method and medical application thereof
07/25/2012CN102603711A Pyridine carboxamides as 11-beta-hsd1 inhibitors
07/25/2012CN102603675A Piperazine compound and application thereof
07/25/2012CN102603666A Cinnamoyl tauryl timonacic compound and application thereof
07/25/2012CN102603663A Polymorphism of valsartan and preparation method of polymorphism of valsartan
07/25/2012CN102603627A Naphthlamide derivative used as protein kinase inhibitor and histone deacetylase inhibitor and preparation method of naphthlamide derivative
07/25/2012CN102603610A 1,3-dihydro-1-oxo-2H-isobenzazole compounds as well as preparation method and use thereof
07/25/2012CN102603575A Rhein-arginine eutectic compound, and preparation method, purification method and application thereof in preparation of medicines for treating diabetic complications
07/25/2012CN102603565A Compounds for treatment of cell proliferative diseases
07/25/2012CN102603519A Kaurene diterpene derivative, medicinal composition thereof and application of kaurene diterpene derivative to medicament
07/25/2012CN102600451A Felodipine ramipril compound sustained-release preparation and preparation method thereof
07/25/2012CN102600446A Traditional Chinese medicine for treating cerebral obstruction
07/25/2012CN102600438A Medicament for treating diabetes mellitus, hypertension, hyperlipidemia and coronary heart disease
07/25/2012CN102600435A Device and formula of traditional Chinese medicine for stabilizing heart and relieving asthma
07/25/2012CN102600422A Traditional Chinese mixture for treating angina pectoris at catabatic period
07/25/2012CN102600420A Medicine composition for blood stasis and qi stagnation
07/25/2012CN102600387A Chinese herbal medicinal preparation for treating acute viral myocarditis complicated with enterotoxaemia
07/25/2012CN102600342A Specific medicine for treating coronary disease
07/25/2012CN102600321A Chinese medicinal compound preparation for treating ischemic cerebrovascular disease and preparation method thereof
07/25/2012CN102600293A Traditional Chinese medicine for treating thromboangiitis obliterans
07/25/2012CN102600260A Medicinal use of composition of amino acids and extracts for preventing and treating senile dementia
07/25/2012CN102600255A Coronary disease treatment capsule
07/25/2012CN102600239A Medicament for treating thromboangitis obliterans and preparation method thereof
07/25/2012CN102600228A Method for preparing gypenoside in gypenoside grains
07/25/2012CN102600227A Compound functional red rice capsule
07/25/2012CN102600215A Method for extracting peganum harmala alkaloid
1 ... 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 ... 1595